Sessions

Implementing New and Enabling Technologies into Existing Processes for Improved Commercial Outcomes
Implementing New and Enabling Technologies into Existing Processes for Improved Commercial Outcomes
Changing the Cell Therapy Landscape with In-Vivo Therapies: Is this a Viable Alternative for Point of Care Therapeutics?
Achieving Best Practice in Quality Control and Assurance
Analytics, Data and IT Tech Solutions: An Overview of Best Practices and Technology
Delivery Solutions, Improvements and Alternatives for Gene & Cell Therapy
Industry 4.0 Approaches Transforming Cell and Gene Therapy
Accelerating the Digitalisation Revolution in Cell and Gene Therapy Development
Viral Vector Development: Safe and Effective Viral Vectors for Therapeutic Success

Implementing New and Enabling Technologies into Existing Processes for Improved Commercial Outcomes

26 Jan 2022
13:30
SPONSORED BY
ARMI | BioFabUSA
Adva Biotechnology
Invetech

13:30 Chairperson’s Opening
Thomas Bollenbach, Chief Technology Officer, ARMI

13:35 Metabolic and Environmental Control-Based Automation, Machine Learning and AI with the Adva X3 Platform

  • Main challenges in autologous manufacturing
  • Can metabolic feedback be used to reduce donor-to-donor variation?
  • Improving manufacturing of cells by metabolic and environmental control coupled with machine learning
  • Adaptive culturing and its implementation in the ADVA X3 automatic manufacturing platform

Ohad Karnieli, Founder & Chief Executive Officer, Adva Biotechnology

13:55 Digital Tools for Data Driven Manufacturing Technology Selection and Deployment

Nathan Moore, Associate Director, Engineering & Automation, Cell Therapies, Takeda

14:15: Considerations for Enabling Treatment & Commercial Outcomes

  • Orchestration efforts leading to improved outcomes
  • Commercial efforts to improve outcomes through patient support
  • AI utilization
  • Manufacturing to product distribution

Dale Hanna, Director of Product, AmerisourceBergen

14:35 Speaker Q&A and Panel Discussion

Including all session speakers and Joined by:

Jon Ellis, Manager, Invetech

Speakers

Thomas Bollenbach
Chief Technology Officer
ARMI
Ohad Karnieli
Founder & CEO
Adva Biotechnology
Nathan Moore
Associate Director, Manufacturing Technologies, Cell Therapies
Takeda
Dale Hanna
Director of Product
AmerisourceBergen
Jon Ellis
Manager
Invetech